Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 2000; 93(Suppl 38): 40–45.
PMCID: PMC1305883

Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Full Text

The Full Text of this article is available as a PDF (83K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Boxerbaum B, Jacobs MR, Cechner RL. Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. Pediatr Pulmonol. 1988;4(3):159–163. [PubMed]
  • Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev. 1991 Jan;4(1):35–51. [PMC free article] [PubMed]
  • Hutchison ML, Govan JR. Pathogenicity of microbes associated with cystic fibrosis. Microbes Infect. 1999 Oct;1(12):1005–1014. [PubMed]
  • Guidelines on the control of methicillin-resistant Staphylococcus aureus in the community. Report of a combined Working Party of the British Society for Antimicrobial Chemotherapy and the Hospital Infection Society. J Hosp Infect. 1995 Sep;31(1):1–12. [PubMed]
  • Lessing MP, Jordens JZ, Bowler IC. When should healthcare workers be screened for methicillin-resistant Staphylococcus aureus? J Hosp Infect. 1996 Nov;34(3):205–210. [PubMed]
  • Cox RA, Conquest C. Strategies for the management of healthcare staff colonized with epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect. 1997 Feb;35(2):117–127. [PubMed]
  • Austin DJ, Anderson RM. Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales. J Infect Dis. 1999 Apr;179(4):883–891. [PubMed]
  • Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev. 1996 Sep;60(3):539–574. [PMC free article] [PubMed]
  • Pamukcu A, Bush A, Buchdahl R. Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulmonol. 1995 Jan;19(1):10–15. [PubMed]
  • Drittanti L, Masciovecchio MV, Gabbarini J, Vega M. Cystic fibrosis: gene therapy or preventive gene transfer? Gene Ther. 1997 Oct;4(10):1001–1003. [PubMed]
  • Henry RL, Mellis CM, Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol. 1992 Mar;12(3):158–161. [PubMed]
  • Grothues D, Koopmann U, von der Hardt H, Tümmler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol. 1988 Oct;26(10):1973–1977. [PMC free article] [PubMed]
  • Kubesch P, Lingner M, Grothues D, Wehsling M, Tümmler B. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung. Scand J Gastroenterol Suppl. 1988;143:77–80. [PubMed]
  • Renders NH, Sijmons MA, van Belkum A, Overbeek SE, Mouton JW, Verbrugh HA. Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings. Res Microbiol. 1997 Jun;148(5):447–454. [PubMed]
  • Speert DP, Campbell ME. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis. J Hosp Infect. 1987 Jan;9(1):11–21. [PubMed]
  • Speert DP, Lawton D, Damm S. Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp. J Pediatr. 1982 Aug;101(2):227–228. [PubMed]
  • Hoogkamp-Korstanje JA, Meis JF, Kissing J, van der Laag J, Melchers WJ. Risk of cross-colonization and infection by Pseudomonas aeruginosa in a holiday camp for cystic fibrosis patients. J Clin Microbiol. 1995 Mar;33(3):572–575. [PMC free article] [PubMed]
  • Ayliffe GA, Babb JR, Collins BJ, Lowbury EJ, Newsom SW. Pseudomonas aeruginosa in hospital sinks. Lancet. 1974 Sep 7;2(7880):578–581. [PubMed]
  • Pedersen SS, Koch C, Høiby N, Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother. 1986 Apr;17(4):505–516. [PubMed]
  • Jensen ET, Giwercman B, Ojeniyi B, Bangsborg JM, Hansen A, Koch C, Fiehn NE, Høiby N. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment. J Hosp Infect. 1997 Jun;36(2):117–122. [PubMed]
  • Zembrzuska-Sadkowska E, Sneum M, Ojeniyi B, Heiden L, Høiby N. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in the Danish Cystic Fibrosis Centre. J Hosp Infect. 1995 Jan;29(1):1–7. [PubMed]
  • Tümmler B, Koopmann U, Grothues D, Weissbrodt H, Steinkamp G, von der Hardt H. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients. J Clin Microbiol. 1991 Jun;29(6):1265–1267. [PMC free article] [PubMed]
  • Mahadeva R, Webb K, Westerbeek RC, Carroll NR, Dodd ME, Bilton D, Lomas DA. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ. 1998 Jun 13;316(7147):1771–1775. [PMC free article] [PubMed]
  • Adams C, Morris-Quinn M, McConnell F, West J, Lucey B, Shortt C, Cryan B, Watson JB, O'Gara F. Epidemiology and clinical impact of Pseudomonas aeruginosa infection in cystic fibrosis using AP-PCR fingerprinting. J Infect. 1998 Sep;37(2):151–158. [PubMed]
  • Govan JR, Nelson JW. Microbiology of lung infection in cystic fibrosis. Br Med Bull. 1992 Oct;48(4):912–930. [PubMed]
  • Nelson JW, Tredgett MW, Sheehan JK, Thornton DJ, Notman D, Govan JR. Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis. Infect Immun. 1990 Jun;58(6):1489–1495. [PMC free article] [PubMed]
  • Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW, Boucher RC. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell. 1998 Dec 23;95(7):1005–1015. [PubMed]
  • Boucher RC. Molecular insights into the physiology of the 'thin film' of airway surface liquid. J Physiol. 1999 May 1;516(Pt 3):631–638. [PubMed]
  • Tredgett MW, Doherty C, Govan JR. Incidence of common pyocin types of Pseudomonas aeruginosa from patients with cystic fibrosis and chronic airways diseases. J Med Microbiol. 1990 Jul;32(3):169–172. [PubMed]
  • Cheng K, Smyth RL, Govan JR, Doherty C, Winstanley C, Denning N, Heaf DP, van Saene H, Hart CA. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet. 1996 Sep 7;348(9028):639–642. [PubMed]
  • Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984 Feb;104(2):206–210. [PubMed]
  • Govan JR, Hughes JE, Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol. 1996 Dec;45(6):395–407. [PubMed]
  • LiPuma JJ. Burkholderia cepacia. Management issues and new insights. Clin Chest Med. 1998 Sep;19(3):473–vi. [PubMed]
  • Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R, Revets H, Lauwers S, Gillis M, Kersters K, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol. 1997 Oct;47(4):1188–1200. [PubMed]
  • Sun L, Jiang RZ, Steinbach S, Holmes A, Campanelli C, Forstner J, Sajjan U, Tan Y, Riley M, Goldstein R. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med. 1995 Jul;1(7):661–666. [PubMed]
  • Sajjan SU, Forstner JF. Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun. 1992 Apr;60(4):1434–1440. [PMC free article] [PubMed]
  • Sajjan US, Corey M, Karmali MA, Forstner JF. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest. 1992 Feb;89(2):648–656. [PMC free article] [PubMed]
  • Sajjan US, Sun L, Goldstein R, Forstner JF. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol. 1995 Feb;177(4):1030–1038. [PMC free article] [PubMed]
  • Mahenthiralingam E, Simpson DA, Speert DP. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol. 1997 Apr;35(4):808–816. [PMC free article] [PubMed]
  • Mahenthiralingam E, Coenye T, Chung JW, Speert DP, Govan JR, Taylor P, Vandamme P. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol. 2000 Feb;38(2):910–913. [PMC free article] [PubMed]
  • Henry DA, Campbell ME, LiPuma JJ, Speert DP. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol. 1997 Mar;35(3):614–619. [PMC free article] [PubMed]
  • Henry D, Campbell M, McGimpsey C, Clarke A, Louden L, Burns JL, Roe MH, Vandamme P, Speert D. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol. 1999 Apr;37(4):1004–1007. [PMC free article] [PubMed]
  • Cazzola G, Amalfitano G, Tonolli E, Perazzoli C, Piacentini I, Mastella G. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study. Acta Paediatr. 1996 May;85(5):554–557. [PubMed]
  • Webb AK, Govan JR. Burkholderia cepacia: another twist and a further threat. Thorax. 1998 May;53(5):333–334. [PMC free article] [PubMed]
  • Ledson MJ, Gallagher MJ, Corkill JE, Hart CA, Walshaw MJ. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax. 1998 May;53(5):432–436. [PMC free article] [PubMed]
  • Webb AK, Egan J. Should patients with cystic fibrosis infected with Burkholderia cepacia undergo lung transplantation? Thorax. 1997 Aug;52(8):671–673. [PMC free article] [PubMed]
  • Govan JR, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, Greening AP, Webb AK. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993 Jul 3;342(8862):15–19. [PubMed]
  • Holmes A, Nolan R, Taylor R, Finley R, Riley M, Jiang RZ, Steinbach S, Goldstein R. An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis. 1999 May;179(5):1197–1205. [PubMed]
  • Ledson MJ, Gallagher MJ, Walshaw MJ. Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual. Thorax. 1998 May;53(5):430–432. [PMC free article] [PubMed]
  • Drabick JA, Gracely EJ, Heidecker GJ, LiPuma JJ. Survival of Burkholderia cepacia on environmental surfaces. J Hosp Infect. 1996 Apr;32(4):267–276. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press